Carboxypeptidase vitellogenic like facilitates resistance to CDK4/6 inhibitors in breast cancer

OBJECTIVE: Inhibitors of cyclin‐dependent kinase 4 and 6 (CDK4/6) are targeted therapeutic drugs for breast cancer treatment. The mechanism of resistance to these inhibitors requires further investigation. METHODS: We used bioinformatics to screen differentially expressed genes between cells that we...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiang, Xu, Xiaojie, Zhang, Lin, Yang, Xuhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101830/
https://www.ncbi.nlm.nih.gov/pubmed/36825764
http://dx.doi.org/10.1111/1759-7714.14829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101830/
https://www.ncbi.nlm.nih.gov/pubmed/36825764
http://dx.doi.org/10.1111/1759-7714.14829

Ejemplares similares